Does CARBIMAZOLE Cause Agranulocytosis? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Agranulocytosis have been filed in association with CARBIMAZOLE. This represents 5.5% of all adverse event reports for CARBIMAZOLE.
37
Reports of Agranulocytosis with CARBIMAZOLE
5.5%
of all CARBIMAZOLE reports
10
Deaths
24
Hospitalizations
How Dangerous Is Agranulocytosis From CARBIMAZOLE?
Of the 37 reports, 10 (27.0%) resulted in death, 24 (64.9%) required hospitalization, and 7 (18.9%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBIMAZOLE. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does CARBIMAZOLE Cause?
Hyperthyroidism (82)
Nausea (66)
Diarrhoea (54)
Acute kidney injury (48)
Toxic epidermal necrolysis (45)
Blister (39)
Condition aggravated (38)
Hypothyroidism (37)
Cholecystitis (35)
Electrolyte imbalance (34)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which CARBIMAZOLE Alternatives Have Lower Agranulocytosis Risk?
CARBIMAZOLE vs CARBOCYSTEINE
CARBIMAZOLE vs CARBOMER
CARBIMAZOLE vs CARBON DIOXIDE
CARBIMAZOLE vs CARBON MONOXIDE
CARBIMAZOLE vs CARBOPLATIN